BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang DH, Xie YJ, Zhao NF, Pan HY, Li MW, Huang HJ. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients. World J Gastroenterol 2015; 21(9): 2746-2753 [PMID: 25759545 DOI: 10.3748/wjg.v21.i9.2746]
URL: https://www.wjgnet.com/1007-9327/full/v21/i9/2746.htm
Number Citing Articles
1
Hui-Lian Wang, Xi Lu, Xudong Yang, Qilan Ning. Efficacy of tenofovir-based rescue therapy in patients with lamivudine-resistant hepatitis B virus: A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology 2016; 40(4): 447 doi: 10.1016/j.clinre.2015.10.005
2
Eun Young Cho, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Yeon Seok Seo, Ji Hoon Kim, Hong Soo Kim, Sae Hwan Lee, Sang Hoon Ahn, Jeong Il Lee, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Woo Lee, In Hee Kim, Hyoung Su Kim, Sang Jong Park, Jeong Mi Lee, Seong Gyu Hwang. Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort StudyGut and Liver 2017; 11(1): 129 doi: 10.5009/gnl15597
3
Apostolos Beloukas, Anna Maria Geretti. Antimicrobial Drug Resistance2017; : 1227 doi: 10.1007/978-3-319-47266-9_26
4
Marcela Krečmerová, Pavel Majer, Rana Rais, Barbara S. Slusher. Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future ProspectsFrontiers in Chemistry 2022; 10 doi: 10.3389/fchem.2022.889737
5
Hyo Jun Ahn, Myeong Jun Song, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Haitao Guo. Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in KoreaPLOS ONE 2017; 12(1): e0170362 doi: 10.1371/journal.pone.0170362
6
Heon Ju Lee, Sang Jin Kim, Young Oh Kweon, Soo Young Park, Jeong Heo, Hyun Young Woo, Jae Seok Hwang, Woo Jin Chung, Chang Hyeong Lee, Byung Seok Kim, Jeong Ill Suh, Won Young Tak, Byoung Kuk Jang, Jose Ignacio Herrero. Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patientsPLOS ONE 2018; 13(1): e0190581 doi: 10.1371/journal.pone.0190581
7
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn. Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)Clinical and Molecular Hepatology 2016; 22(4): 443 doi: 10.3350/cmh.2016.0037
8
Akinobu Tawada, Tatsuo Kanda, Fumio Imazeki, Osamu Yokosuka. Prevention of hepatitis B virus-associated liver diseases by antiviral therapyHepatology International 2016; 10(4): 574 doi: 10.1007/s12072-016-9720-y
9
Sreekumar Othumpangat, Sidhartha D. Ray, John D. Noti. A Worldwide Yearly Survey of New Data in Adverse Drug ReactionsSide Effects of Drugs Annual 2016; 38: 261 doi: 10.1016/bs.seda.2016.08.022
10
In Suk Min, Chang Hun Lee, Ik Sang Shin, Na Eun Lee, Hong Seon Son, Seung Bum Kim, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration RateGut and Liver 2019; 13(1): 93 doi: 10.5009/gnl18183
11
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Guía Clínica de Hepatitis BRevista de Gastroenterología de México 2021; 86(4): 403 doi: 10.1016/j.rgmx.2021.04.002
12
Massimo Fasano, Paolo Maggi, Armando Leone, Anna Volpe, Jose Ramon Fiore, Gioacchino Angarano, Teresa Antonia Santantonio. Long-term efficacy and safety of switching from lamivudine + adefovir to tenofovir disoproxil fumarate in virologically suppressed patientsDigestive and Liver Disease 2017; 49(5): 530 doi: 10.1016/j.dld.2017.01.140
13
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis BRevista de Gastroenterología de México (English Edition) 2021; 86(4): 403 doi: 10.1016/j.rgmxen.2021.04.002
14
Manuel Rodríguez, Juan Manuel Pascasio, Enrique Fraga, Javier Fuentes, Martín Prieto, Gloria Sánchez-Antolín, José Luis Calleja, Esther Molina, María Luisa García-Buey, María Ángeles Blanco, Javier Salmerón, María Lucía Bonet, José Antonio Pons, José Manuel González, Miguel Ángel Casado, Francisco Jorquera, the TENOSIMP-B Research Group. Tenofovir <i>vs</i> lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B studyWorld Journal of Gastroenterology 2017; 23(41): 7459-7469 doi: 10.3748/wjg.v23.i41.7459
15
Hui-Lian Wang, Xi Lu, Xudong Yang, Nan Xu. Antiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-AnalysisGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/3435965